These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3336272)

  • 1. Reduction of tumor growth following treatment with a glutamine antimetabolite.
    Chance WT; Cao L; Kim MW; Nelson JL; Fischer JE
    Life Sci; 1988; 42(1):87-94. PubMed ID: 3336272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and acivicin improve host nutrition and prevent tumor growth during total parenteral nutrition.
    Chance WT; Cao L; Fischer JE
    Ann Surg; 1988 Oct; 208(4):524-31. PubMed ID: 3140745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acivicin reduces tumor growth during total parenteral nutrition (TPN).
    Chance WT; Cao L; Nelson JL; Foley-Nelson T; Fischer JE
    Surgery; 1987 Aug; 102(2):386-94. PubMed ID: 3112985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of tumor and host to hyperalimentation and antiglutamine treatments.
    Chance WT; Cao LQ; Fischer JE
    JPEN J Parenter Enteral Nutr; 1990; 14(2):122-8. PubMed ID: 2112618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clenbuterol plus acivicin decrease tumor growth and increase muscle mass in rats maintained on total parenteral nutrition.
    Chance WT; Cao L; Zhang FS; Fischer JE
    Am J Surg; 1991 Jan; 161(1):51-6. PubMed ID: 1899011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
    Aoki T; Sebolt J; Weber G
    Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
    Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
    Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
    Nichols KE; Chitneni SR; Moore JO; Weinberg JB
    Blood; 1989 Oct; 74(5):1728-37. PubMed ID: 2790198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of total nitrogen, asparagine, and glutamine on MCA tumor growth in the Fischer 344 rat.
    Popp MB; Enrione EB; Wagner SC; Chance WT
    Surgery; 1988 Aug; 104(2):152-60. PubMed ID: 2899915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal behavioral and neurochemical effects of the CNS toxic amino acid antitumor agent, acivicin.
    McGovren JP; Williams MG; Tang AH; VonVoigtlander PF; Piercey MF; Einspahr FJ; Schreur PJ
    Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):215-29. PubMed ID: 2711026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme targets of antiglutamine agents in cancer chemotherapy.
    Prajda N
    Adv Enzyme Regul; 1985; 24():207-23. PubMed ID: 2424283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
    Huber KR; Rosenfeld H; Roberts J
    Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
    Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
    Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acivicin: a new glutamine antagonist in clinical trials.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B
    J Clin Oncol; 1984 Sep; 2(9):1064-71. PubMed ID: 6470756
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperammonemia in anorectic tumor-bearing rats.
    Chance WT; Cao L; Nelson JL; Foley-Nelson T; Fischer JE
    Life Sci; 1988; 43(1):67-74. PubMed ID: 3164438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gamma-Glutamyl transpeptidase mediation of tumor glutathione utilization in vivo.
    Hochwald SN; Harrison LE; Rose DM; Anderson M; Burt ME
    J Natl Cancer Inst; 1996 Feb; 88(3-4):193-7. PubMed ID: 8632493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acivicin on glutamine transport by rat renal brush border membrane vesicles.
    Sastrasinh S; Sastrasinh M
    J Lab Clin Med; 1986 Oct; 108(4):301-8. PubMed ID: 2876045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting energy expenditure of host and tumor is similar in rats with methylcholanthrene-induced sarcoma.
    Freund HR; Kim MW; Muggia-Sullam M; Chance WT; Fischer JE
    Arch Surg; 1987 Oct; 122(10):1151-2. PubMed ID: 3662795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.
    Jayaram HN; Cooney DA; Ryan JA; Neil G; Dion RL; Bono VH
    Cancer Chemother Rep; 1975; 59(3):481-91. PubMed ID: 1147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.